====== Telis Bioscience ====== {{ :pharmaceutical_companies:telis_bioscience.jpeg?200|}} **Telis Bioscience** is an American biotechnology company based in [[united_states:massachusetts:Cambridge]], [[united_states:Massachusetts]]. ===== History ===== Telis was founded in 2019 by [[:Grigory Khimulya]] and [[:Kyle Fish]].((//Telis Bioscience - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved March 27, 2023, from https://www.crunchbase.com/organization/telis-bioscience)) ((Grigory Khimulya [@grigonomics]. (2020, September 23). //“Life update: for the past year @fish_kyle3 and I have been building Telis Bioscience, a venture-backed biotech company in Cambridge, MA engineering high-impact protein therapeutics . We’re hiring! (1/5)”// [Tweet]. Twitter. http://archive.today/2023.03.27-011210/https://twitter.com/grigonomics/status/1308768978756567042)) In December 2021, Telis pivoted to focus on developing a [[:COVID-19 vaccines|COVID-19 vaccine]] under a new name, [[Alvea]], which launched in January 2022.((McGrath, K. (2022, February 16). //Alvea Launches Scalable, Shelf- Stable DNA Vaccine Development against New SARS-CoV-2 Variants.// PR Newswire. https://web.archive.org/web/20220513024500/https://www.prnewswire.com/news-releases/alvea-launches-scalable-shelf--stable-dna-vaccine-development-against-new-sars-cov-2-variants-301483557.html)) ===== Organization ===== ==== Funding ==== Telis received $2 million from [[:Alameda Research]].((Ashworth, L. (2022, December 19). //How to spend a million dollars, by Sam Bankman-Fried.// Financial Times. http://archive.today/2023.01.11-055404/https://www.ft.com/content/9a3b4b78-b18b-4d1f-b28b-05a73525aa61)) ==== Personnel ==== ^ Name ^ Position ^ Notes ^ | [[:Grigory Khimulya]] | Co-founder & Chief Executive Officer | - | | [[:Kyle Fish]] | Co-founder & Chief Technology Officer | - | ===== External links ===== * [[https://www.linkedin.com/company/telisbio/|LinkedIn]] * [[https://wiki.whiteroseintelligence.com/en/Telis-Bioscience|White Rose Wiki]]